封面
市場調查報告書
商品編碼
1435120

API 中間體市場:按類型、原料、應用和最終用戶分類 - 全球預測 2024-2030

API Intermediates Market by Type (Bulk Drug Intermediates, Chemical Intermediates), Raw Material (Carbonyl, Chloro, Nitrile), Application, End User - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年API中間體市場規模為1,786.3億美元,預估2024年將達1926.5億美元,2030年將達3,032.3億美元,複合年成長率為7.85%。

API中間體的全球市場

主要市場統計
基準年[2023] 1786.3億美元
預測年份 [2024] 1926.5億美元
預測年份 [2030] 3032.3億美元
複合年成長率(%) 7.85%
API中間體市場-IMG1

API(活性藥物成分)中間體是在 API 製造中充當構建模組的化合物。 API 是醫藥產品中發現的生物活性化合物,可以使製造的藥物達到所需的治療效果。 API 中間體在原料藥製造的化學反應中充當起始材料或關鍵成分。確保原料藥中間體的品質對於生產有效的藥物是必要的,同時滿足藥物功效和安全性的監管標準。對原料藥中間體的需求不斷成長,這是由於慢性病的流行需要生產各種學名藥,以及政府促進生物製藥生產活動的努力。近年來,隨著罕見疾病數量的增加,特殊原料藥的生產變得越來越重要。然而,原料藥中間體的複雜採購以及與維持原料藥安全和品質相關的監管問題嚴重影響了市場的有效擴張。市場相關人員不斷致力於推進API中間體的合成和加工方法,以確保更安全的生產方法。此外,專門從事原料藥製造的受託製造廠商正在顯著增加,為市場擴張創造了機會。此外,透過利用人工智慧(AI)和機器學習(ML)等數位技術的進步,可以更有效地預測新藥的候選中間體並簡化研究過程。

區域洞察

美洲市場的特點是API中間體相關研發活動的投資大幅增加。該地區領先的製藥公司致力於透過併購、收購以及與致力於創新研究和改進技術的小公司建立夥伴關係來擴大其能力,以經濟有效地生產複雜的原料藥。由美國食品藥物管理局(FDA) 和加拿大衛生署主導的嚴格法律規範確保 API 中間體的高品質標準。亞太地區憑藉其具有成本競爭力的製造能力,已成為 API 中間體市場的重要參與者。在促進藥品出口的政​​府政策的推動下,推動這一成長的主要國家是印度和中國。該地區正致力於透過技術和培訓投資以及主要企業之間的合作和原料藥的批量生產來提高品質標準,以滿足已開發地區不斷成長的需求。歐洲傳統上專注於化學合成來生產 API 中間體,使其在有機合成化學製程方面保持強大的專業知識。德國、英國等成熟市場的特點是歐洲藥品管理局 (EMA) 執行嚴格的法規,確保高品質標準。歐洲公司正在利用現有基礎設施和熟練勞動力的優勢來吸引全球客戶進行原料藥中間體製造,從而增強該地區充滿活力的合約研究和受託製造服務 (CRAMS) 生態系統。

FPNV定位矩陣

FPNV定位矩陣對於評估API中間體市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市場佔有率分析

市場佔有率分析是一種綜合工具,可對 API 中間體市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解:

1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。

2-市場開拓:我們深入研究利潤豐厚的新興市場並分析其在成熟細分市場的滲透率。

3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題:

1-API中間體市場的市場規模與預測是多少?

2-API中間體市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?

3-API中間體市場的技術趨勢與法律規範是什麼?

4-API中間體市場主要供應商的市場佔有率是多少?

5-進入API中間體市場合適的型態和策略手段是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的流行和對學名藥的需求
      • 政府促進生物製藥生產活動的舉措
      • 擴大採用罕見疾病和用於治療罕見疾病的特殊原料藥
    • 抑制因素
      • API 中間體的複雜採購與智慧財產權問題
    • 機會
      • API中間體的合成與加工研究進展
      • 專門從事原料藥製造的契約製造組織的興起
    • 任務
      • API 中間體安全與品質的監管複雜性
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 API 中間體市場:依類型

  • 原料藥中間體
  • 化學中間體

第7章原料藥中間體市場:依原料分類

  • 庫洛洛
  • 丁腈橡膠
  • 硝基

第8章原料藥中間體市場:依應用分類

  • 止痛藥
  • 感染疾病
  • 抗癌劑
  • 抗糖尿病藥
  • 心血管藥物

第 9 章 API 中間體市場:依最終使用者分類

  • 生物技術和製藥公司
  • CMO
  • 調查

第10章 美洲原料藥中間體市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太原料藥中間體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東及非洲原料藥中間體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析:主要企業
  • 主要企業競爭情境分析
    • 併購
    • 投資、資金籌措
    • 獎項/獎勵/擴展

第14章競爭產品組合

  • 主要公司簡介
    • Aarti Pharmalabs Limited
    • Actylis
    • Alzchem Group
    • API Corporation by UBE Corp.
    • Atul Ltd.
    • Aurobindo Pharma
    • BASF SE
    • Cambrex Corp.
    • Cation Pharma
    • Divi's Laboratories Limited
    • Dr. Reddy's Laboratories Ltd.
    • Espee Group
    • Evonik Industries AG
    • Flamma Group
    • Hikal Ltd.
    • Kaneka Corporation
    • Levachem Company Ltd.
    • Lupin Ltd.
    • Nectar Lifesciences Ltd.
    • Noah Chemicals
    • Pfizer Inc.
    • Proviron Holding NV
    • Sandoo Pharmaceuticals and Chemicals Co., Ltd.
    • Sandoz International GmbH by Novartis AG
    • Sanofi
    • Sarex
    • Shree Ganesh Remedies Ltd.
    • Sumitomo Chemical Co., Ltd.
    • Vertellus
    • ZCL Chemicals Ltd. by Advent International
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-CF699CF4142B

[199 Pages Report] The API Intermediates Market size was estimated at USD 178.63 billion in 2023 and expected to reach USD 192.65 billion in 2024, at a CAGR 7.85% to reach USD 303.23 billion by 2030.

Global API Intermediates Market

KEY MARKET STATISTICS
Base Year [2023] USD 178.63 billion
Estimated Year [2024] USD 192.65 billion
Forecast Year [2030] USD 303.23 billion
CAGR (%) 7.85%
API Intermediates Market - IMG1

API (Active Pharmaceutical Ingredients) intermediates are chemical compounds that cater as building blocks in the production of APIs. APIs are biologically active compounds in pharmaceutical drugs that enable the desired therapeutic effect of the drug produced. API intermediates act as the starting materials or key components in the chemical reactions that lead to the making of APIs. Ensuring the quality of API intermediates is necessary to create an effective medication while meeting the regulatory standards for drug efficacy and safety. The expanding need for API intermediates has been driven by the prevalence of chronic diseases demanding the production of various generic drugs and government initiatives promoting biopharmaceutical manufacturing activities. With the rise in cases of orphan and rare diseases, recent years have observed an increasing emphasis on the manufacturing of specialty APIs. However, complicated sourcing of API intermediates and regulatory concerns associated with maintaining the safety and quality of APIs significantly impact the efficient expansion of the market. Market players are constantly working on elevating the synthesizing and processing methods of API intermediates to ensure a safer production method. There has also been a major increase in the number of contract manufacturing organizations specializing in API production, which has created better opportunities for market enlargement. Moreover, leveraging advances in digital technologies such as artificial intelligence (AI) and machine learning (ML) could also help streamline research processes by predicting potential intermediates for novel drugs more effectively.

Regional Insights

The Americas market is characterized by a substantial increase in investments toward R&D activities related to the API intermediates. Major regional pharmaceutical companies focus on expanding their capabilities through mergers, acquisitions, or collaborations with smaller firms engaged in innovative research and in technology upgradation for the cost-effective production of complex APIs. Strict regulatory frameworks led by the U.S. Food & Drug Administration (FDA) in the United States and Health Canada in Canada ensure high-quality standards for API intermediates. APAC has emerged as a vital player in the API intermediates market due to its cost-competitive manufacturing capabilities. Major countries contributing to this growth are India and China, with supportive government policies that promote pharmaceutical exports. The region also witnesses collaborations among key players or bulk API production while focusing on improving quality standards through investments in technology and training to capture growing demand in developed regions. Europe has been traditionally focusing on chemical synthesis for producing API intermediates which enables them to maintain strong expertise in synthetic organic chemistry processes. Mature markets such as Germany, France, and the United Kingdom are characterized by strict regulations governed by the European Medicines Agency (EMA), ensuring high-quality standards. European companies are leveraging the advantages of their well-established infrastructure and skilled workforce to attract global clients for API intermediate manufacturing, leading to the emergence of a vibrant contract research and manufacturing services (CRAMS) ecosystem in the region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the API Intermediates Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the API Intermediates Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the API Intermediates Market, highlighting leading vendors and their innovative profiles. These include Aarti Pharmalabs Limited, Actylis, Alzchem Group, API Corporation by UBE Corp., Atul Ltd., Aurobindo Pharma, BASF SE, Cambrex Corp., Cation Pharma, Divi's Laboratories Limited, Dr. Reddy's Laboratories Ltd., Espee Group, Evonik Industries AG, Flamma Group, Hikal Ltd., Kaneka Corporation, Levachem Company Ltd., Lupin Ltd., Nectar Lifesciences Ltd., Noah Chemicals, Pfizer Inc., Proviron Holding NV, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Sandoz International GmbH by Novartis AG, Sanofi, Sarex, Shree Ganesh Remedies Ltd., Sumitomo Chemical Co., Ltd., Vertellus, and ZCL Chemicals Ltd. by Advent International.

Market Segmentation & Coverage

This research report categorizes the API Intermediates Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Bulk Drug Intermediates
    • Chemical Intermediates
  • Raw Material
    • Carbonyl
    • Chloro
    • Nitrile
    • Nitro
  • Application
    • Analgesics
    • Anti-Infective Drugs
    • Anticancer Drugs
    • Antidiabetic Drugs
    • Cardiovascular Drugs
  • End User
    • Biotech & Pharmaceutical Companies
    • CMO
    • Research Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the API Intermediates Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the API Intermediates Market?

3. What are the technology trends and regulatory frameworks in the API Intermediates Market?

4. What is the market share of the leading vendors in the API Intermediates Market?

5. Which modes and strategic moves are suitable for entering the API Intermediates Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. API Intermediates Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and need for generic drugs
      • 5.1.1.2. Government initiatives promoting biopharmaceutical manufacturing activities
      • 5.1.1.3. Increased adoption of specialty APIs for rare and orphan disease treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Complicated sourcing of API intermediates and intellectual property concerns
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in synthesizing and processing of API intermediates
      • 5.1.3.2. Rise of contract manufacturing organizations specializing in API production
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory complexity concerning the safety and quality of API intemediates
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. API Intermediates Market, by Type

  • 6.1. Introduction
  • 6.2. Bulk Drug Intermediates
  • 6.3. Chemical Intermediates

7. API Intermediates Market, by Raw Material

  • 7.1. Introduction
  • 7.2. Carbonyl
  • 7.3. Chloro
  • 7.4. Nitrile
  • 7.5. Nitro

8. API Intermediates Market, by Application

  • 8.1. Introduction
  • 8.2. Analgesics
  • 8.3. Anti-Infective Drugs
  • 8.4. Anticancer Drugs
  • 8.5. Antidiabetic Drugs
  • 8.6. Cardiovascular Drugs

9. API Intermediates Market, by End User

  • 9.1. Introduction
  • 9.2. Biotech & Pharmaceutical Companies
  • 9.3. CMO
  • 9.4. Research Laboratories

10. Americas API Intermediates Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific API Intermediates Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa API Intermediates Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Merger & Acquisition
      • 13.3.1.1. Sigachi Industries Forays into API business, Acquires Majority Stake in Trimax Bio Sciences
    • 13.3.2. Investment & Funding
      • 13.3.2.1. FLAMMA to Invest USD 200 Million Over the Next 3 Years
    • 13.3.3. Award, Recognition, & Expansion
      • 13.3.3.1. Boehringer Ingelheim and German Chancellor Olaf Scholz Lay The Foundation Stone for 285 million EUR Innovation Center

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Aarti Pharmalabs Limited
    • 14.1.2. Actylis
    • 14.1.3. Alzchem Group
    • 14.1.4. API Corporation by UBE Corp.
    • 14.1.5. Atul Ltd.
    • 14.1.6. Aurobindo Pharma
    • 14.1.7. BASF SE
    • 14.1.8. Cambrex Corp.
    • 14.1.9. Cation Pharma
    • 14.1.10. Divi's Laboratories Limited
    • 14.1.11. Dr. Reddy's Laboratories Ltd.
    • 14.1.12. Espee Group
    • 14.1.13. Evonik Industries AG
    • 14.1.14. Flamma Group
    • 14.1.15. Hikal Ltd.
    • 14.1.16. Kaneka Corporation
    • 14.1.17. Levachem Company Ltd.
    • 14.1.18. Lupin Ltd.
    • 14.1.19. Nectar Lifesciences Ltd.
    • 14.1.20. Noah Chemicals
    • 14.1.21. Pfizer Inc.
    • 14.1.22. Proviron Holding NV
    • 14.1.23. Sandoo Pharmaceuticals and Chemicals Co., Ltd.
    • 14.1.24. Sandoz International GmbH by Novartis AG
    • 14.1.25. Sanofi
    • 14.1.26. Sarex
    • 14.1.27. Shree Ganesh Remedies Ltd.
    • 14.1.28. Sumitomo Chemical Co., Ltd.
    • 14.1.29. Vertellus
    • 14.1.30. ZCL Chemicals Ltd. by Advent International
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. API INTERMEDIATES MARKET RESEARCH PROCESS
  • FIGURE 2. API INTERMEDIATES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. API INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. API INTERMEDIATES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. API INTERMEDIATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. API INTERMEDIATES MARKET DYNAMICS
  • FIGURE 7. API INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. API INTERMEDIATES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
  • FIGURE 10. API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. API INTERMEDIATES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. API INTERMEDIATES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. API INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. API INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. API INTERMEDIATES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. API INTERMEDIATES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL API INTERMEDIATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. API INTERMEDIATES MARKET SIZE, BY BULK DRUG INTERMEDIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. API INTERMEDIATES MARKET SIZE, BY CHEMICAL INTERMEDIATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 9. API INTERMEDIATES MARKET SIZE, BY CARBONYL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. API INTERMEDIATES MARKET SIZE, BY CHLORO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. API INTERMEDIATES MARKET SIZE, BY NITRILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. API INTERMEDIATES MARKET SIZE, BY NITRO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. API INTERMEDIATES MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. API INTERMEDIATES MARKET SIZE, BY ANTI-INFECTIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. API INTERMEDIATES MARKET SIZE, BY ANTICANCER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. API INTERMEDIATES MARKET SIZE, BY ANTIDIABETIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. API INTERMEDIATES MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. API INTERMEDIATES MARKET SIZE, BY BIOTECH & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. API INTERMEDIATES MARKET SIZE, BY CMO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. API INTERMEDIATES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES API INTERMEDIATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA API INTERMEDIATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM API INTERMEDIATES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. API INTERMEDIATES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 192. API INTERMEDIATES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. API INTERMEDIATES MARKET LICENSE & PRICING